Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has maintained a 'Buy' rating on OrthoPediatrics (NASDAQ:KIDS) but lowered the price target from $55 to $37.
November 07, 2023 | 6:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
OrthoPediatrics' price target has been lowered from $55 to $37 by Needham, though the 'Buy' rating is maintained.
The lowering of the price target by a significant margin could potentially lead to a short-term decrease in the stock price of OrthoPediatrics. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100